{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T01:11:16Z","timestamp":1783905076759,"version":"3.55.0"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,7,12]]},"DOI":"10.7759\/cureus.112537","type":"journal-article","created":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T00:39:19Z","timestamp":1783903159000},"source":"Crossref","is-referenced-by-count":0,"title":["Prognostic Factors and Survival Outcomes in Pediatric Acute Lymphoblastic Leukemia: A Real-World Retrospective Cohort Study from a Tertiary Care Center in North India"],"prefix":"10.7759","author":[{"given":"Faisal R","family":"Guru","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suhail","family":"Ahmad Wani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shumail","family":"Bashir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nisar Ahmad","family":"Syed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohmad Hussain","family":"Mir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ulfat","family":"Ara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tazeen","family":"Jeelani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zafirah","family":"Zahir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aiffa","family":"Aiman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra1400972","article-title":"Acute lymphoblastic leukemia in children","volume":"373","author":"Hunger SP","year":"2015","unstructured":"Hunger SP, Mullighan CG. Acute lymphoblastic leukemia in children. N Engl J Med. 2015, 373:1541-52. 10.1056\/NEJMra1400972","journal-title":"N Engl J Med"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1038\/s41571-018-0136-6","article-title":"Somatic and germline genomics in paediatric acute lymphoblastic leukaemia","volume":"16","author":"Pui CH","year":"2019","unstructured":"Pui CH, Nichols KE, Yang JJ. Somatic and germline genomics in paediatric acute lymphoblastic leukaemia. Nat Rev Clin Oncol. 2019, 16:227-40. 10.1038\/s41571-018-0136-6","journal-title":"Nat Rev Clin Oncol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra052603","article-title":"Treatment of acute lymphoblastic leukemia","volume":"354","author":"Pui CH","year":"2006","unstructured":"Pui CH, Evans WE. Treatment of acute lymphoblastic leukemia. N Engl J Med. 2006, 354:166-78. 10.1056\/NEJMra052603","journal-title":"N Engl J Med"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1001\/jamaoncol.2017.0580","article-title":"Association of minimal residual disease with clinical outcome in pediatric and adult acute lymphoblastic leukemia: a meta-analysis","volume":"3","author":"Berry DA","year":"2017","unstructured":"Berry DA, Zhou S, Higley H, et al.. Association of minimal residual disease with clinical outcome in pediatric and adult acute lymphoblastic leukemia: a meta-analysis. JAMA Oncol. 2017, 3:e170580. 10.1001\/jamaoncol.2017.0580","journal-title":"JAMA Oncol"},{"key":"ref5","unstructured":"National Cancer Institute. Childhood acute lymphoblastic leukemia treatment (PDQ\u00ae)-health professional version. (2025). Accessed: July 11, 2026: https:\/\/www.cancer.gov\/types\/leukemia\/hp\/child-all-treatment-pdq."},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2007-09-112920","article-title":"Risk-adjusted therapy of acute lymphoblastic leukemia can decrease treatment burden and improve survival: treatment results of 2169 unselected pediatric and adolescent patients enrolled in the trial ALL-BFM 95","volume":"111","author":"M\u00f6ricke A","year":"2008","unstructured":"M\u00f6ricke A, Reiter A, Zimmermann M, et al.. Risk-adjusted therapy of acute lymphoblastic leukemia can decrease treatment burden and improve survival: treatment results of 2169 unselected pediatric and adolescent patients enrolled in the trial ALL-BFM 95. Blood. 2008, 111:4477-89. 10.1182\/blood-2007-09-112920","journal-title":"Blood"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0906079106","article-title":"Evolution in health and medicine Sackler colloquium: consanguinity, human evolution, and complex diseases","volume":"107 Suppl 1","author":"Bittles AH","year":"2010","unstructured":"Bittles AH, Black ML. Evolution in health and medicine Sackler colloquium: consanguinity, human evolution, and complex diseases. Proc Natl Acad Sci U S A. 2010, 107 Suppl 1:1779-86. 10.1073\/pnas.0906079106","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1038\/nature15817","article-title":"Pharmacogenomics in the clinic","volume":"526","author":"Relling MV","year":"2015","unstructured":"Relling MV, Evans WE. Pharmacogenomics in the clinic. Nature. 2015, 526:343-50. 10.1038\/nature15817","journal-title":"Nature"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.4103\/0019-509X.55546","article-title":"Epidemiology of childhood cancer in India","volume":"46","author":"Arora RS","year":"2009","unstructured":"Arora RS, Eden TO, Kapoor G. Epidemiology of childhood cancer in India. Indian J Cancer. 2009, 46:264-73. 10.4103\/0019-509X.55546","journal-title":"Indian J Cancer"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1023\/a:1008366814109","article-title":"Acute lymphoblastic leukemia in India: an analysis of prognostic factors using a single treatment regimen","volume":"10","author":"Advani S","year":"1999","unstructured":"Advani S, Pai S, Venzon D, et al.. Acute lymphoblastic leukemia in India: an analysis of prognostic factors using a single treatment regimen. Ann Oncol. 1999, 10:167-76. 10.1023\/a:1008366814109","journal-title":"Ann Oncol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2014.59.1636","article-title":"Childhood acute lymphoblastic leukemia: progress through collaboration","volume":"33","author":"Pui CH","year":"2015","unstructured":"Pui CH, Yang JJ, Hunger SP, et al.. Childhood acute lymphoblastic leukemia: progress through collaboration. J Clin Oncol. 2015, 33:2938-48. 10.1200\/JCO.2014.59.1636","journal-title":"J Clin Oncol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2009-10-248146","article-title":"Molecular response to treatment redefines all prognostic factors in children and adolescents with B-cell precursor acute lymphoblastic leukemia: results in 3184 patients of the AIEOP-BFM ALL 2000 study","volume":"115","author":"Conter V","year":"2010","unstructured":"Conter V, Bartram CR, Valsecchi MG, et al.. Molecular response to treatment redefines all prognostic factors in children and adolescents with B-cell precursor acute lymphoblastic leukemia: results in 3184 patients of the AIEOP-BFM ALL 2000 study. Blood. 2010, 115:3206-14. 10.1182\/blood-2009-10-248146","journal-title":"Blood"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1038\/leu.2009.257","article-title":"Long-term results of five consecutive trials in childhood acute lymphoblastic leukemia performed by the ALL-BFM study group from 1981 to 2000","volume":"24","author":"M\u00f6ricke A","year":"2010","unstructured":"M\u00f6ricke A, Zimmermann M, Reiter A, et al.. Long-term results of five consecutive trials in childhood acute lymphoblastic leukemia performed by the ALL-BFM study group from 1981 to 2000. Leukemia. 2010, 24:265-84. 10.1038\/leu.2009.257","journal-title":"Leukemia"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMp048313","article-title":"Saving the children--improving childhood cancer treatment in developing countries","volume":"352","author":"Ribeiro RC","year":"2005","unstructured":"Ribeiro RC, Pui CH. Saving the children--improving childhood cancer treatment in developing countries. N Engl J Med. 2005, 352:2158-60. 10.1056\/NEJMp048313","journal-title":"N Engl J Med"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1596\/978-1-4648-0349-9_ch7","article-title":"Improving outcomes for children with cancer in LMICs","volume":"16","author":"Gupta S","year":"2015","unstructured":"Gupta S, Bonilla M, Fuentes SL, et al.. Improving outcomes for children with cancer in LMICs. Lancet Oncol. 2015, 16:247-55. 10.1596\/978-1-4648-0349-9_ch7","journal-title":"Lancet Oncol"},{"key":"ref16","doi-asserted-by":"crossref","DOI":"10.1182\/blood.V96.8.2691","article-title":"Clinical importance of minimal residual disease in childhood acute lymphoblastic leukemia","volume":"96","author":"Coustan-Smith E","year":"2000","unstructured":"Coustan-Smith E, Sancho J, Hancock ML, et al.. Clinical importance of minimal residual disease in childhood acute lymphoblastic leukemia. Blood. 2000, 96:2691-6.","journal-title":"Blood"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2008-01-132837","article-title":"Clinical significance of minimal residual disease in childhood acute lymphoblastic leukemia and its relationship to other prognostic factors: a Children's Oncology Group study","volume":"111","author":"Borowitz MJ","year":"2008","unstructured":"Borowitz MJ, Devidas M, Hunger SP, et al.. Clinical significance of minimal residual disease in childhood acute lymphoblastic leukemia and its relationship to other prognostic factors: a Children's Oncology Group study. Blood. 2008, 111:5477-85. 10.1182\/blood-2008-01-132837","journal-title":"Blood"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1182\/asheducation-2010.1.7","article-title":"Minimal residual disease in acute lymphoblastic leukemia","volume":"2010","author":"Campana D","year":"2010","unstructured":"Campana D. Minimal residual disease in acute lymphoblastic leukemia. Hematology Am Soc Hematol Educ Program. 2010, 2010:7-12. 10.1182\/asheducation-2010.1.7","journal-title":"Hematology Am Soc Hematol Educ Program"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1038\/sj.leu.2401780","article-title":"New definition of remission in childhood acute lymphoblastic leukemia","volume":"14","author":"Pui CH","year":"2000","unstructured":"Pui CH, Campana D. New definition of remission in childhood acute lymphoblastic leukemia. Leukemia. 2000, 14:783-5. 10.1038\/sj.leu.2401780","journal-title":"Leukemia"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2011-03-338707","article-title":"Late MRD response determines relapse risk overall and in subsets of childhood T-cell ALL: results of the AIEOP-BFM-ALL 2000 study","volume":"118","author":"Schrappe M","year":"2011","unstructured":"Schrappe M, Valsecchi MG, Bartram CR, et al.. Late MRD response determines relapse risk overall and in subsets of childhood T-cell ALL: results of the AIEOP-BFM-ALL 2000 study. Blood. 2011, 118:2077-84. 10.1182\/blood-2011-03-338707","journal-title":"Blood"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1007\/s11899-016-0337-y","article-title":"Treatment of childhood acute lymphoblastic leukemia: prognostic factors and clinical advances","volume":"11","author":"Vrooman LM","year":"2016","unstructured":"Vrooman LM, Silverman LB. Treatment of childhood acute lymphoblastic leukemia: prognostic factors and clinical advances. Curr Hematol Malig Rep. 2016, 11:385-94. 10.1007\/s11899-016-0337-y","journal-title":"Curr Hematol Malig Rep"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1038\/leu.2013.135","article-title":"The MLL recombinome of acute leukemias in 2013","volume":"27","author":"Meyer C","year":"2013","unstructured":"Meyer C, Hofmann J, Burmeister T, et al.. The MLL recombinome of acute leukemias in 2013. Leukemia. 2013, 27:2165-76. 10.1038\/leu.2013.135","journal-title":"Leukemia"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(12)62187-4","article-title":"Acute lymphoblastic leukaemia","volume":"381","author":"Inaba H","year":"2013","unstructured":"Inaba H, Greaves M, Mullighan CG. Acute lymphoblastic leukaemia. Lancet. 2013, 381:1943-55. 10.1016\/S0140-6736(12)62187-4","journal-title":"Lancet"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2003.10.116","article-title":"Childhood T-cell acute lymphoblastic leukemia: the Dana-Farber Cancer Institute acute lymphoblastic leukemia consortium experience","volume":"21","author":"Goldberg JM","year":"2003","unstructured":"Goldberg JM, Silverman LB, Levy DE, et al.. Childhood T-cell acute lymphoblastic leukemia: the Dana-Farber Cancer Institute acute lymphoblastic leukemia consortium experience. J Clin Oncol. 2003, 21:3616-22. 10.1200\/JCO.2003.10.116","journal-title":"J Clin Oncol"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1007\/s12687-011-0072-y","article-title":"Consanguineous marriages : preconception consultation in primary health care settings","volume":"3","author":"Hamamy H","year":"2012","unstructured":"Hamamy H. Consanguineous marriages : preconception consultation in primary health care settings. J Community Genet. 2012, 3:185-92. 10.1007\/s12687-011-0072-y","journal-title":"J Community Genet"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1016\/j.pcl.2014.09.004","article-title":"Biology of childhood acute lymphoblastic leukemia","volume":"62","author":"Bhojwani D","year":"2015","unstructured":"Bhojwani D, Yang JJ, Pui CH. Biology of childhood acute lymphoblastic leukemia. Pediatr Clin North Am. 2015, 62:47-60. 10.1016\/j.pcl.2014.09.004","journal-title":"Pediatr Clin North Am"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/499272-prognostic-factors-and-survival-outcomes-in-pediatric-acute-lymphoblastic-leukemia-a-real-world-retrospective-cohort-study-from-a-tertiary-care-center-in-north-india","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T00:39:21Z","timestamp":1783903161000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/499272-prognostic-factors-and-survival-outcomes-in-pediatric-acute-lymphoblastic-leukemia-a-real-world-retrospective-cohort-study-from-a-tertiary-care-center-in-north-india"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,12]]},"references-count":26,"URL":"https:\/\/doi.org\/10.7759\/cureus.112537","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7,12]]}}}